A Study of Necitumumab Monotherapy and the QT/QTc Interval in Patient With Advanced Solid Tumors

NCT01624467 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

BIOLOGICAL: Necitumumab

Sponsor

Eli Lilly and Company